About Prismic Pharmaceuticals
Prismic Pharmaceuticals is a company based in Worcester (United States) founded in 2011 was acquired by FSD Pharma in April 2019. Prismic Pharmaceuticals has raised $1.2 million across 1 funding round from investors including FSD Pharma. Prismic Pharmaceuticals offers products and services including Motor Reviews, Buying-Selling Platform, and Motor Information Service.
- Headquarter Worcester, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.2 M (USD)
in 1 rounds
-
Latest Funding Round
$1.2 M (USD), Seed
Feb 20, 2013
- Investors
-
Employee Count
Not available
-
Acquired by
FSD Pharma
(Apr 23, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prismic Pharmaceuticals
Prismic Pharmaceuticals offers a comprehensive portfolio of products and services, including Motor Reviews, Buying-Selling Platform, and Motor Information Service.
Provides detailed reviews and information on popular motor models.
Facilitates online buying and selling of motor-related items.
Offers data on specific motors like Motor 1 and Motor 2.
Funding Insights of Prismic Pharmaceuticals
Prismic Pharmaceuticals has successfully raised a total of $1.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.2 million completed in February 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prismic Pharmaceuticals
Prismic Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FSD Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis company engaged in cultivation, processing, and manufacturing related activities
|
Locked | Locked | Locked |
Investor details for Prismic Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prismic Pharmaceuticals
Investment portfolio details for Prismic Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prismic Pharmaceuticals
Detailed financials for Prismic Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prismic Pharmaceuticals Comparisons
Peer comparison for Prismic Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prismic Pharmaceuticals
Detailed competitors of Prismic Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prismic Pharmaceuticals
Complete news archive for Prismic Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prismic Pharmaceuticals
Prismic Pharmaceuticals was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Prismic Pharmaceuticals is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.
Prismic Pharmaceuticals is a funded company, having raised a total of $1.2M across 1 funding round to date.
Prismic Pharmaceuticals is a development-stage specialty pharmaceutical company, which focuses on the research and development of patent protected products to address inflammation and oxidative stress associated with renal and mental health disorders. Currently has two pharmaceutically active ingredients, ultra-micronized palmitoylethanolamide, and ultra-pure EPA-based Omega-3, in development to address disorders associated with kidney disease, mental health, and chronic pain. Plan to develop proprietary products in two distinct FDA categories, prescription Medical Foods and Prescription Drugs. Medical food pipeline includes Neurepa, Nefrogesic, Nefrosil and Neurepa Le. Prescription Drugs pipeline includes ultra-micronized palmitoylethanolamide (UM PEA) Morphine, UM PEA Pregabalin, UM PEA Hydrocodone, UM PEA Oxycodone, UM PEA and UM PEA Silymarin.
Prismic Pharmaceuticals offers Motor Reviews, Buying-Selling Platform, and Motor Information Service.
Prismic Pharmaceuticals has 1 investor. Key investors include FSD Pharma.